General information, not medical advice. BPC-157 and TB-500 are not FDA-approved. Medical disclaimer · Editorial policy

Questions to Ask a Clinician About Peptides | Checklist

By the BPC-TB Guide editorial team · Last updated October 9, 2026

# Questions to ask a clinician about BPC-157, TB-500 or any peptide

Print this page and bring it to your appointment. It lists questions only. It gives no dose and no advice, and it does not tell you what the answers should be. A licensed clinician who knows your history is the right person to answer. Write the answers in the margin and keep the page. Regulatory status is dated 2026-10-09 and can change.

FDA status

  1. Is this product an FDA-approved drug? No FDA-approved drug contains BPC-157 or TB-500 as of 2026-10-09. Ask what FDA status the clinician says applies to this specific product, and ask where that is written.
  2. What is the legal route by which this product reaches me, and who is responsible for its quality?
  3. If the label says "research use only", what does the clinician say that means for me?

Evidence for your specific use

  1. Which human trials, if any, tested this peptide for my condition? Ask for the name or the PubMed record number.
  2. If the support is from animals or cells, what does the clinician say that tells us about a person?
  3. What care options for my condition do have human trial support, and how strong is that support?
  4. What would the clinician expect to see if it worked, and how and when would we check?

Safety and interactions

  1. What is documented about harms, and what is unknown?
  2. Could it interact with my medicines, supplements or conditions? Ask specifically about anything involving blood vessels, clotting, cancer history or pregnancy.
  3. What would make the clinician stop, and what should I do if something goes wrong?

Drug testing and sports

  1. Am I drug tested by a sport, employer or licensing body? Ask the clinician to check the current WADA Prohibited List or the testing body's own list. The WADA 2026 List, in effect from 2026-01-01, names BPC-157 and thymosin beta 4 derivatives such as TB-500.

Who monitors, and what is documented

  1. Who would monitor me, how often, and with what tests?
  2. What will be written in my medical record about the product, its source and its batch?
  3. Who do I contact if I have a question or a reaction, and what happens if that person is unavailable?

Before you decide

Note the answers, and note any you did not get. A clear "we do not know" is a useful answer. For background on any item, see the home page and the medical disclaimer.

General information, not medical advice.